| P-PBD group n = 27 | NP-PBD group n = 25 | HC group n = 19 | F/χ2 | p |
---|---|---|---|---|---|
Age (Years) | 15.4 (1.55) | 14.8 (1.94) | 14.2 (1.57) | 2.858 | 0.064 |
Sex (Male/Female) | 11/16 | 14/11 | 7/12 | 1.930 | 0.381 |
Education (Years) | 8.37 (1.50) | 7.96 (2.11) | 7.47 (2.22) | 1.204 | 0.306 |
IQ | 102.9 (13.8) | 105.0 (12.5) | 105.3 (7.51) | 0.311 | 0.733 |
Illness course (Months) | 16.7 (12.3) | 17.3 (16.8) | Â | 0.018 | 0.895 |
Onset age (Years) | 14.2 (1.54) | 13.3 (2.09) | Â | 2.939 | 0.093 |
Episode times | 3.59 (1.65) | 4.71 (7.09) | Â | 0.631 | 0.431 |
PBD-I/PBD-II | 16/11 | 17/8 | Â | 0.428 | 0.513 |
YMRS | 12.4 (13.1)b | 15.4 (14.4)a | 3.63 (2.06) | 5.437 | 0.006 |
MFQ | 15.2 (14.2)a | 11.7 (10.6) | 6.11 (3.33) | 3.862 | 0.026 |
Psychotic symptom, n (%) | |||||
 Current | 15 (55.6) |  |  |  |  |
 Past | 12 (44.4) |  |  |  |  |
Current status, n (%) | |||||
 Mania | 8 (29.6) | 9 (36.0) |  | 0.239 | 0.625 |
 Depression | 8 (29.6) | 7 (28.0) |  | 0.017 | 0.897 |
 Euthymia | 11 (40.8) | 9 (36.0) |  | 0.318 | 0.573 |
Family history (Y/N) | 5/22 | 7/18 | Â | 0.657 | 0.417 |
Treatment, n (%) | |||||
 None | 3 (11.1) | 11 (44.0) |  | 7.137 | 0.008 |
 Lithium | 12 (44.4) | 7 (28.0) |  | 1.514 | 0.219 |
 Valproate | 15 (55.6) | 9 (36.0) |  | 1.997 | 0.158 |
 Antipsychotics | 22 (81.5) | 12 (48.0) |  | 11.15 | 0.001 |
 Antidepressants | 2 (7.41) | 1 (4.0) |  | 0.272* | 0.602 |
Comorbidity n (%) | |||||
 Anxiety | 7 (25.9) | 3 (12.0) |  | 1.590* | 0.207 |
 ADHD | 2 (7.41) | 1 (4.0) |  | 0.272* | 0.602 |
 OCD | 1 (3.70) | 1 (4.0) |  | 0.003* | 0.956 |